Sabba Stephen L Insider Trades

Insider Trading History

Track insider trading activity for Sabba Stephen L. See latest buy and sell transactions across all companies.

Holdings

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price

Insider Trades History

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price
Ligand Pharmaceuticals
Ligand Pharmaceuticals LGND
Director
Holding Value $7.74M 32,793 shares
Last Trade
Mar 23, 2026 Sale (Open Market)Shares sold on the open market or in a private sale.
$208k 1,000 shares
$207.87
$235.91
Ligand Pharmaceuticals
Ligand Pharmaceuticals LGND
Director
Holding Value $7.97M 33,793 shares
Last Trade
Mar 03, 2026 Sale (Open Market)Shares sold on the open market or in a private sale.
$410k 2,034 shares
$201.50
$235.91
Ligand Pharmaceuticals
Ligand Pharmaceuticals LGND
Director
Holding Value $0 0 shares
Last Trade
Mar 03, 2026 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$415k 2,034 shares
$204.24
$235.91
Ligand Pharmaceuticals
Ligand Pharmaceuticals LGND
Director
Holding Value $8.45M 35,827 shares
Last Trade
Mar 03, 2026 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$415k 2,034 shares
$204.24
$235.91
Ligand Pharmaceuticals
Ligand Pharmaceuticals LGND
Director
Holding Value $7.97M 33,793 shares
Last Trade
Jun 06, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$613k 5,783 shares
$105.99
$235.91
Ligand Pharmaceuticals
Ligand Pharmaceuticals LGND
Director
Holding Value $0 0 shares
Last Trade
Apr 01, 2025 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$252k 2,406 shares
$104.82
$235.91
Ligand Pharmaceuticals
Ligand Pharmaceuticals LGND
Director
Holding Value $7.69M 32,584 shares
Last Trade
Apr 01, 2025 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$252k 2,406 shares
$104.82
$235.91
Ligand Pharmaceuticals
Ligand Pharmaceuticals LGND
Director
Holding Value $7.12M 30,178 shares
Last Trade
Jun 14, 2024 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$436k 5,444 shares
$80.06
$235.91
Ligand Pharmaceuticals
Ligand Pharmaceuticals LGND
Director
Holding Value $98.8k 419 shares
Last Trade
Mar 05, 2024 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$195k 2,893 shares
$67.53
$235.91
Ligand Pharmaceuticals
Ligand Pharmaceuticals LGND
Director
Holding Value $7.27M 30,819 shares
Last Trade
Mar 05, 2024 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$214k 2,893 shares
$74.00
$235.91
Ligand Pharmaceuticals
Ligand Pharmaceuticals LGND
Director
Holding Value $6.82M 28,926 shares
Last Trade
Mar 05, 2024 Sale (Open Market)Shares sold on the open market or in a private sale.
$141k 1,893 shares
$74.30
$235.91
Ligand Pharmaceuticals
Ligand Pharmaceuticals LGND
Director
Holding Value $1.29M 5,461 shares
Last Trade
Jun 09, 2023 Sale (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$403k 5,461 shares
$73.76
$235.91
Ligand Pharmaceuticals
Ligand Pharmaceuticals LGND
Director
Holding Value $6.35M 26,926 shares
Last Trade
Jun 09, 2023 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$84.2k 1,142 shares
$73.76
$235.91
Ligand Pharmaceuticals
Ligand Pharmaceuticals LGND
Director
Holding Value $6.08M 25,784 shares
Last Trade
May 10, 2023 Sale (Open Market)Shares sold on the open market or in a private sale.
$494k 6,408 shares
$77.13
$235.91
Ligand Pharmaceuticals
Ligand Pharmaceuticals LGND
Director
Holding Value $7.59M 32,192 shares
Last Trade
May 10, 2023 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$497k 6,408 shares
$77.59
$235.91
Ligand Pharmaceuticals
Ligand Pharmaceuticals LGND
Director
Holding Value $219k 927 shares
Last Trade
May 10, 2023 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$497k 6,408 shares
$77.59
$235.91
Ligand Pharmaceuticals
Ligand Pharmaceuticals LGND
Director
Holding Value $1.56M 6,623 shares
Last Trade
Dec 22, 2022 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$444k 6,623 shares
$67.03
$235.91
Ligand Pharmaceuticals
Ligand Pharmaceuticals LGND
Director
Holding Value $6.15M 26,065 shares
Last Trade
Jun 10, 2022 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$79.6k 1,004 shares
$79.29
$235.91
Ligand Pharmaceuticals
Ligand Pharmaceuticals LGND
Director
Holding Value $5.91M 25,061 shares
Last Trade
Jun 04, 2021 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$72.7k 630 shares
$115.39
$235.91
Ligand Pharmaceuticals
Ligand Pharmaceuticals LGND
Director
Holding Value $771k 3,269 shares
Last Trade
Jun 04, 2021 Sale (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$377k 3,269 shares
$115.39
$235.91

See more insider trades for free

Join Stockcircle to see more insider trades and be the first to know about new executive transactions.

Sign Up